Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 247

The DOI matches its Crossref record.

Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction

Cinque, Paola, Scarpellini, Paolo, Vago, Luca, Linde, Annika, Lazzarin, Adriano · 1997 · AIDS

Abstract

Introduction Neurological complications afflict the majority of people who are infected with HIV. These include opportunistic infections, tumours, vascular and metabolic complications, and also disorders that are unique to AIDS itself and associated with infection of the nervous system by HIV [1]. Although the use of different antimicrobial treatments has led to a significant increase in the survival of AIDS patients, many of the nervous system disorders still represent a diagnostic and therapeutic challenge. The clinical diagnosis of central nervous system (CNS) diseases in patients with AIDS is based on neurological examination and neuroimaging studies. Further examinations, such as standard analysis of cerebrospinal fluid (CSF), electroencephalography and neuropsychological assessments, may also be useful. None of these investigations, however, provides specific information, and only the identification of a pathogen in the CSF or brain makes a diagnosis of aetiology possible. In some cases, conventional microbiological techniques applied to analyse CSF, such as the isolation of bacteria, mycobacteria and fungi, and the detection of Cryptococcus neoformans polysaccharide antigen, are adequate for diagnosis. CSF examination may also be helpful in demonstrating the presence of tumour cells in cases of metastatic CNS lymphoma, or in revealing Venereal Disease Research Laboratory (VDRL) test reactivity in cases of neurosyphilis, but these conditions represent only a minority of CNS complications. On the other hand, brain biopsy is indicated in limited instances, although this is often impracticable because of the critical condition of the patients. CNS diseases in AIDS patients are therefore often diagnosed on clinical grounds, by either excluding other conditions or evaluating the response to specific treatments. A definitive aetiological diagnosis can frequently only be established at post-mortem examination. Over the past decade, DNA amplification-based techniques, primarily the polymerase chain reaction (PCR), have made a massive contribution towards improving the diagnosis of many microbial diseases. The PCR identification of microbial genomes in CSF found its first successful applications in CNS infections during the early 1990s, when it was used for the diagnosis of herpes simplex encephalitis, and enteroviral and tuberculous meningitis in immunocompetent patients [2–4]. Following the first investigations, CSF PCR was assessed and found to be reliable for diagnosing several infectious CNS diseases [5–7]. This review will briefly describe CSF PCR principles and procedures, focus on its use in diagnosis of the various HIV-related complications whilst also considering the conventional methods for diagnosis, and discuss its use in clinical practice. PCR of cerebrospinal fluid The main property of PCR, accounting for its extraordinary sensitivity, is its ability to amplify a small quantity of target DNA molecules to produce considerably larger amounts (over 106 DNA copies), which can then be visualized by means of common laboratory procedures. The technique is based on the use of oligonucleotides (primers), which specifically recognize and anneal to the target DNA, and a thermostable DNA polymerase, which forms new DNA strains starting from single nucleotides. DNA amplification takes place during repeated cycles of heating and cooling, and these allow the denaturation of DNA, the annealing of the primer to the denatured DNA strand, and final extension of the DNA itself [8,9]. In clinical microbiology, PCR is used to identify the nucleic acids of microbial pathogens that are present in samples. Several PCR protocols have been developed for each microorganism in order to obtain adequate specificity and sensitivity of detection; these may differ in terms of the primers used, choice of buffer and the heating and cooling cycling conditions. The primers are usually designed to recognize highly conserved regions of the genome in order to avoid false-negative results. They may also be complementary to sequences that are repeated many times in the microbial genome, such as insertion elements, thereby enhancing PCR sensitivity [10]. The variants of classical PCR include ‘multiplex’ and ‘nested’ PCR. The former enables the identification of more than one microorganism in the PCR or more primer each specific for a single The the of the first amplification to be a of primers that is the first a which amplification and the sensitivity of DNA molecules can be to a PCR reaction in order to of that are present in the samples. These are by the primers and are to the as the but can be by or the of DNA can be by means of different procedures. The technique of the of DNA of the on with with DNA that are complementary to the target DNA may or for the the of DNA to a or The are with or other which are for the identification of the only the specificity of PCR but may also its sensitivity protocols have been used for the of CSF The

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002030-199701000-00003

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 247

Metadata

Authors
Cinque, P., Scarpellini, P., Vago, L., Linde, A., & Lazzarin, A.
Venue
AIDS
Published
1997-01
Volume
11
Issue
1
Pages
1-17
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2324009744
Cited by
247
References
0
FWCI
5.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. https://app.cochat.ai/papers/10.1097/00002030-199701000-00003
The paper
Cinque, P., Scarpellini, P., Vago, L., Linde, A., & Lazzarin, A. (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. https://doi.org/10.1097/00002030-199701000-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.